Grindeks: medicines to become more expensive because of new European requirements
Due to the adoption of a verification system to check safety of medicines, medicines are expected to become more expensive, said Juris Bundulis, board chairman of Grindeks.
He says adoption of a verification system will require significant investments from medicine producers. With that, price rise for medicines is unavoidable. «We have to consider how this will affect patients, because medicines will most definitely become more expensive. For example, Grindeks has to invest several million euros to implement serialization requirements. Equipment manufacturers are happy – their business will definitely bloom,» said Bundulis. At the same time, he says counterfeit medicines are not distributed by legal pharmacies, which are subject to the new system. The internet is used to distribute those products. This is why it is important to explain to patients that buying medicines on the internet comes with risk of purchased medicines having a detrimental effect on their health.
On top of that, it is nearly impossible to identify counterfeit medicines distributors on the internet. If patients purchase low-quality medicines in pharmacies, it is clear who suppliers and distributors are. Additionally, they have to compensate damages caused by their medicines. «Legislation and patients’ rights are very clear and guaranteed,» said Bundulis.
Grindeks board chairman also said it is wrong for the current regulation to cover many companies on which the planned verification system will not apply. He also notes that the argument that only 1% of the entire medicines turnover goes through cases of exception, which is unacceptable. «If there is a hole in market supervision, this 1% can quickly grow into 10%,» says the board chairman of Grindeks. Read the full article on bnn-news.com